We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Atrial Fibrillation/Sinus Rhythm Before and After Cardioversion

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01779674
First Posted: January 30, 2013
Last Update Posted: January 8, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
RWTH Aachen University
  Purpose
This study´s aim is to collect scientific data about patients with atrial inflammation by two principles of sensors measuring congestive heart failure.

Condition
Atrial Fibrillation

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by RWTH Aachen University:

Primary Outcome Measures:
  • scientific data [ Time Frame: 1 hour ]

Enrollment: 25
Study Start Date: August 2011
Study Completion Date: April 2012
Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
patients with atrial fibrillation
Criteria

Inclusion Criteria:

  • patients with atrial fibrillation and planned cardioversion
  • male and female patients aged at least 18 years
  • patients being able to understand and to follow the study staff´s instructions
  • signed informed consent

Exclusion Criteria:

  • persons being hosted in an institution by administrative order or court injunction
  • pregnancy or breast feeding
  • persons not being able to consent
  • persons with implanted electronic devices
  • material incompatiblity
  • acute or chronic inflammation of the external or middle ear canal
  • abnormal anatomic ear canal (congenital or pathological)
  • persons in a dependent relationship to the investigator or employment contract
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01779674


Locations
Germany
Univeristy Hospital Aachen
Aachen, North Rhine Westfalia, Germany, 52074
Sponsors and Collaborators
RWTH Aachen University
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: RWTH Aachen University
ClinicalTrials.gov Identifier: NCT01779674     History of Changes
Other Study ID Numbers: 10-079
First Submitted: January 28, 2013
First Posted: January 30, 2013
Last Update Posted: January 8, 2014
Last Verified: January 2014

Additional relevant MeSH terms:
Atrial Fibrillation
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes


To Top